Basics of androgen synthesis and action
Androgens are essential sex steroid hormones for both sexes. Testosterone (T) is the
predominant androgen in males, while in adult females, T concentrations are about 15-fold …
predominant androgen in males, while in adult females, T concentrations are about 15-fold …
Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome
CY Zheng, YX Yu, X Bai - Seminars in Cell & Developmental Biology, 2024 - Elsevier
Polycystic ovary syndrome (PCOS) refers to a condition that often has 'poly'liquid containing
sacks around ovaries. It affects reproductive-aged females giving rise to menstrual and …
sacks around ovaries. It affects reproductive-aged females giving rise to menstrual and …
[HTML][HTML] Nesfatin-1, dopamine, and NADPH levels in infertile women with polycystic ovary syndrome: is there a relationship between their levels and metabolic and …
Background: Polycystic ovary syndrome (PCOS) is commonest endocrine disease occurring
in women of reproductive age. This study conducted to clarify altered concentrations of …
in women of reproductive age. This study conducted to clarify altered concentrations of …
Common endocrine disorders associated with the polycystic ovary syndrome
I Abdelazim, O Amer, MM Farghali - Menopause Review/Przegląd …, 2020 - termedia.pl
Common endocrine disorders associated with the polycystic ovary syndrome Journals
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii Advances in …
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii Advances in …
Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome
DE Berbrier, CA Leone, TE Adler… - Journal of Applied …, 2023 - journals.physiology.org
Polycystic ovary syndrome (PCOS) is associated with endothelial dysfunction; whether this
is attributable to comorbid hyperandrogenism and/or obesity remains to be established …
is attributable to comorbid hyperandrogenism and/or obesity remains to be established …
Vitamin D and vitamin D receptor polymorphism in Asian adolescents with primary dysmenorrhea
A Donayeva, A Amanzholkyzy, R Nurgaliyeva… - BMC Women's …, 2023 - Springer
Background The expression of vitamin D receptor in the normal endometrium and ovaries
supports the role of vitamin D in local immunity and inflammatory cytokines regulation …
supports the role of vitamin D in local immunity and inflammatory cytokines regulation …
[PDF][PDF] The relation between vitamin D and the adolescents' mid-luteal estradiol and progesterone.
A Donayeva, A Amanzholkyzy… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: The aim of this study was to detect the effect of vitamin D (Vit. D) intake on the
mid-luteal estradiol (E2), and progesterone (P), and the relation between vit. D, and the …
mid-luteal estradiol (E2), and progesterone (P), and the relation between vit. D, and the …
DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies
Background Polycystic ovarian syndrome is a heterogenous endocrine disorder
characterized by irregular menstrual cycles, hirsuitism and polycystic ovaries. It is further …
characterized by irregular menstrual cycles, hirsuitism and polycystic ovaries. It is further …
Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial
WE Mohammed, MM Abbas, IA Abdelazim… - Menopause Review …, 2022 - termedia.pl
Results The endometrial thickness was significantly higher among the C/S than the CC
group during the first 3 months (9.6±1.2 vs. 8.7±1.0 mm, respectively, p= 0.003) and after …
group during the first 3 months (9.6±1.2 vs. 8.7±1.0 mm, respectively, p= 0.003) and after …
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized …
BAA De Hollanda, VM Prizão, MM de Souza… - Journal of Diabetes and …, 2024 - Elsevier
Background The efficacy of GLP1 receptor agonists (GLP1-RAs) in treating polycystic
ovarian syndrome (PCOS) remains unclear. While GLP1-RAs are known to promote weight …
ovarian syndrome (PCOS) remains unclear. While GLP1-RAs are known to promote weight …